$22.09
-0.62-2.73%
At Close: -
$22.00
-0.09-0.41%
After Hours: Jul 19, 6:46 PM EDT
15 minutes delayed
Comments
Loading...
Lemonade
LMNDNYSE
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Lemonade (NYSE:LMND) Stock, Analyst Ratings, Price Targets, Forecasts
Lemonade Inc has a consensus price target of $29 based on the ratings of 13 analysts. The high is $95 issued by JMP Securities on November 10, 2021. The low is $9 issued by BMO Capital on September 28, 2023. The 3 most-recent analyst ratings were released by Jefferies, Piper Sandler, and JMP Securities on May 7, 2024, May 2, 2024, and April 15, 2024, respectively. With an average price target of $24.67 between Jefferies, Piper Sandler, and JMP Securities, there's an implied 12.12% upside for Lemonade Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Jefferies
Piper Sandler
JMP Securities
Keefe, Bruyette & Woods
Morgan Stanley
1calculated from analyst ratings
Analyst Ratings for Lemonade
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/07/2024 | Buy Now | -27.27% | Jefferies | Yaron Kinar | $14 → $16 | Maintains | Underperform | Get Alert |
| 05/02/2024 | Buy Now | -18.18% | Piper Sandler | Arvind Ramnani | $17 → $18 | Maintains | Neutral | Get Alert |
| 04/15/2024 | Buy Now | 81.82% | JMP Securities | Karol Chmiel | → $40 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/04/2024 | Buy Now | -18.18% | Keefe, Bruyette & Woods | Thomas McJoynt-Griffith | $16 → $18 | Maintains | Market Perform | Get Alert |
| 02/29/2024 | Buy Now | -22.73% | Piper Sandler | Arvind Ramnani | → $17 | Reiterates | Neutral → Neutral | Get Alert |
| 02/28/2024 | Buy Now | -36.36% | Morgan Stanley | Michael Phillips | $13 → $14 | Maintains | Underweight | Get Alert |
| 12/01/2023 | Buy Now | — | Oppenheimer | Jason Helfstein | — | Downgrade | Outperform → Perform | Get Alert |
| 11/07/2023 | Buy Now | -45.45% | Morgan Stanley | Michael Phillips | $11 → $12 | Maintains | Underweight | Get Alert |
| 11/02/2023 | Buy Now | -50% | Morgan Stanley | Michael Phillips | $10 → $11 | Maintains | Underweight | Get Alert |
| 10/11/2023 | Buy Now | -54.55% | Morgan Stanley | Michael Phillips | $15 → $10 | Maintains | Underweight | Get Alert |
| 09/28/2023 | Buy Now | -59.09% | BMO Capital | Michael Zaremski | $8 → $9 | Maintains | Underperform | Get Alert |
| 08/04/2023 | Buy Now | -22.73% | Piper Sandler | Arvind Ramnani | $18 → $17 | Maintains | Neutral | Get Alert |
| 08/03/2023 | Buy Now | -31.82% | Morgan Stanley | Michael Phillips | $14 → $15 | Maintains | Underweight | Get Alert |
| 07/12/2023 | Buy Now | 81.82% | JMP Securities | Karol Chmiel | → $40 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 06/20/2023 | Buy Now | -36.36% | Morgan Stanley | Michael Phillips | → $14 | Initiates | → Underweight | Get Alert |
| 05/09/2023 | Buy Now | -22.73% | Barclays | Tracy Benguigui | $16 → $17 | Maintains | Equal-Weight | Get Alert |
| 05/05/2023 | Buy Now | -18.18% | Piper Sandler | Arvind Ramnani | → $18 | Reiterates | → Neutral | Get Alert |
| 05/04/2023 | Buy Now | -45.45% | B of A Securities | Joshua Shanker | $14 → $12 | Maintains | Underperform | Get Alert |
| 05/04/2023 | Buy Now | 81.82% | JMP Securities | Karol Chmiel | → $40 | Reiterates | → Market Outperform | Get Alert |
| 04/18/2023 | Buy Now | 81.82% | JMP Securities | Matthew Carletti | → $40 | Reiterates | → Market Outperform | Get Alert |
| 04/10/2023 | Buy Now | -47.73% | Jefferies | Yaron Kinar | $13 → $11.5 | Maintains | Underperform | Get Alert |
| 02/24/2023 | Buy Now | -27.27% | Barclays | Ross Sandler | $18 → $16 | Maintains | Equal-Weight | Get Alert |
| 02/24/2023 | Buy Now | -18.18% | Piper Sandler | Arvind Ramnani | $19 → $18 | Maintains | Neutral | Get Alert |
| 01/20/2023 | Buy Now | -54.55% | BMO Capital | Michael Zaremski | → $10 | Initiates | → Underperform | Get Alert |
| 01/18/2023 | Buy Now | -13.64% | Piper Sandler | Arvind Ramnani | $20 → $19 | Maintains | Neutral | Get Alert |
| 11/17/2022 | Buy Now | 9.09% | Keefe, Bruyette & Woods | Thomas McJoynt-Griffith | → $24 | Initiates | → Market Perform | Get Alert |
| 11/10/2022 | Buy Now | -18.18% | Barclays | Tracy Benguigui | $28 → $18 | Maintains | Equal-Weight | Get Alert |
| 11/10/2022 | Buy Now | -9.09% | Piper Sandler | Arvind Ramnani | $25 → $20 | Maintains | Neutral | Get Alert |
| 08/10/2022 | Buy Now | 27.27% | Barclays | Tracy Benguigui | $20 → $28 | Maintains | Equal-Weight | Get Alert |
| 08/10/2022 | Buy Now | 13.64% | Piper Sandler | Arvind Ramnani | $20 → $25 | Maintains | Neutral | Get Alert |
| 07/18/2022 | Buy Now | -9.09% | Piper Sandler | Arvind Ramnani | $24 → $20 | Downgrade | Overweight → Neutral | Get Alert |
| 05/13/2022 | Buy Now | -9.09% | Barclays | Tracy Benguigui | $22 → $20 | Maintains | Equal-Weight | Get Alert |
| 05/11/2022 | Buy Now | 36.36% | Oppenheimer | Jason Helfstein | $45 → $30 | Maintains | Outperform | Get Alert |
| 05/11/2022 | Buy Now | 81.82% | JMP Securities | Matthew Carletti | $95 → $40 | Maintains | Market Outperform | Get Alert |
| 05/11/2022 | Buy Now | 9.09% | Piper Sandler | Arvind Ramnani | $32 → $24 | Maintains | Overweight | Get Alert |
| 03/04/2022 | Buy Now | 27.27% | Morgan Stanley | Michael Phillips | $74 → $28 | Maintains | Equal-Weight | Get Alert |
| 02/25/2022 | Buy Now | 104.55% | Oppenheimer | Jason Helfstein | $85 → $45 | Maintains | Outperform | Get Alert |
| 02/25/2022 | Buy Now | 45.45% | Piper Sandler | Arvind Ramnani | $54 → $32 | Maintains | Overweight | Get Alert |
| 01/13/2022 | Buy Now | 145.45% | Piper Sandler | Arvind Ramnani | $84 → $54 | Maintains | Overweight | Get Alert |
| 01/06/2022 | Buy Now | 95.45% | Barclays | Tracy Benguigui | $62 → $43 | Maintains | Equal-Weight | Get Alert |
| 11/19/2021 | Buy Now | 122.73% | Jefferies | Yaron Kinar | — | Initiates | → Underperform | Get Alert |
| 11/10/2021 | Buy Now | 331.82% | JMP Securities | Andrew Boone | — | Maintains | Market Outperform | Get Alert |
| 11/10/2021 | Buy Now | 286.36% | Oppenheimer | Jason Helfstein | — | Maintains | Outperform | Get Alert |
| 11/10/2021 | Buy Now | 181.82% | Barclays | Tracy Benguigui | — | Maintains | Equal-Weight | Get Alert |
| 10/19/2021 | Buy Now | 209.09% | Barclays | Tracy Benguigui | — | Maintains | Equal-Weight | Get Alert |
| 10/15/2021 | Buy Now | 236.36% | Morgan Stanley | Michael Phillips | — | Maintains | Equal-Weight | Get Alert |
| 08/17/2021 | Buy Now | 140.91% | Wolfe Research | Michael Zaremski | — | Initiates | → Underperform | Get Alert |
| 08/06/2021 | Buy Now | 331.82% | Oppenheimer | Jason Helfstein | — | Maintains | Outperform | Get Alert |
| 08/06/2021 | Buy Now | 345.45% | Piper Sandler | Arvind Ramnani | — | Maintains | Overweight | Get Alert |
FAQ
What is the target price for Lemonade (LMND) stock?
The latest price target for Lemonade (NYSE:LMND) was reported by Jefferies on May 7, 2024. The analyst firm set a price target for $16.00 expecting LMND to fall to within 12 months (a possible -27.27% downside). 13 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Lemonade (LMND)?
The latest analyst rating for Lemonade (NYSE:LMND) was provided by Jefferies, and Lemonade maintained their underperform rating.
When was the last upgrade for Lemonade (LMND)?
There is no last upgrade for Lemonade
When was the last downgrade for Lemonade (LMND)?
The last downgrade for Lemonade Inc happened on December 1, 2023 when Oppenheimer changed their price target from N/A to N/A for Lemonade Inc.
When is the next analyst rating going to be posted or updated for Lemonade (LMND)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Lemonade, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Lemonade was filed on May 7, 2024 so you should expect the next rating to be made available sometime around May 7, 2025.
Is the Analyst Rating Lemonade (LMND) correct?
While ratings are subjective and will change, the latest Lemonade (LMND) rating was a maintained with a price target of $14.00 to $16.00. The current price Lemonade (LMND) is trading at is $22.00, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.